2018
DOI: 10.1016/j.aca.2018.04.022
|View full text |Cite
|
Sign up to set email alerts
|

Rapid detection of CALR type 1 and type 2 mutations using PNA-LNA clamping loop-mediated isothermal amplification on a CD-like microfluidic chip

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
9
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
5
2
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(9 citation statements)
references
References 22 publications
0
9
0
Order By: Relevance
“…In particular, the DNA-binding protein MutS from T. aquaticus is of particular interest, which became the basis for the detection of nucleotide polymorphisms in one of the asymmetric methods of isothermal amplification [ 126 ]. Improvement of primer design algorithms and rational inclusion of modified nucleotides, such as LNA and PNA, in their sequence [ 127 , 128 ] can increase the storage stability of primers and lead to the emergence of more specific allele-specific LAMP methods.…”
Section: Discussionmentioning
confidence: 99%
“…In particular, the DNA-binding protein MutS from T. aquaticus is of particular interest, which became the basis for the detection of nucleotide polymorphisms in one of the asymmetric methods of isothermal amplification [ 126 ]. Improvement of primer design algorithms and rational inclusion of modified nucleotides, such as LNA and PNA, in their sequence [ 127 , 128 ] can increase the storage stability of primers and lead to the emergence of more specific allele-specific LAMP methods.…”
Section: Discussionmentioning
confidence: 99%
“…Studies have shown that almost all MPNs are associated with either a JAK2 V617F mutation or changes in JAK2 signaling, either directly or indirectly (Nangalia et al, 2013). JAK2 drives CML by phosphorylating BCR‐ABL1 and triggers 50‒60% of ET with the myeloproliferative leukemia virus oncogene ( MPL ) (3%‒5%) and calreticulin ( CALR ) (30%‒40%) responsible for the rest of ETs (Cao et al, 2018; Gángó et al, 2018). Although CALR mutations have been identified as markers of MPNs, the underlying molecular process remains largely unrevealed, prompting us to further explore the mechanism of CALR ‐mediated ETs at the molecular level.…”
Section: Introductionmentioning
confidence: 99%
“…In general, the treatment of MPNs using disease modifiers is further complicated, as the specific treatment depends on the individual mutation [ 16 ]. Diagnosis of MPNs is aided by the detection of the various associated mutations by polymerase chain reaction, sequencing, or other DNA-based methods [ 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 ], but the detection of disease-associated mutations may be facilitated or aided by mutation-specific immunohistochemistry (IHC) [ 31 , 32 , 33 ], methods which supplement each other. Moreover, antibodies such as these are invaluable reagents for studying the properties of CRT in relation to MPN.…”
Section: Introductionmentioning
confidence: 99%